Doctor profile · Federal record
Dr. John Yost, M.D.
Dermatology Physician (CMS: Dermatology) · Redwood City, CA
- NPI 1336451137
- Accepts Medicare
- MIPS 77.9 / 100 · 2023
- 16 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
450 Broadway St, Stanford Dept of Dermatology, Pavilion C, 2Nd Floor
Redwood City, CA 940633132
(650) 721-7190
Credentials & registration
- NPI registered
- July 2010 — 16 yrs on file
- Profile last updated
- September 3, 2014
- Year of graduation
- 2010 — 16 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- California #A131385
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1336451137. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
7,141
Distinct HCPCS
10
Medicare allowed
$378,789
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 3,385 | 525 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 904 | 645 | $95 | |
17000 |
Destruction of precancer skin growth, 1 growth | 843 | 611 | $57 | |
11102 |
Biopsy of related skin growth, first growth | 440 | 378 | $103 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 393 | 393 | $117 | |
17110 |
Destruction of skin growth, 1-14 growths | 266 | 228 | $121 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 216 | 159 | $134 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 154 | 136 | $60 | |
11103 |
Biopsy of related skin growth, each additional growth | 134 | 89 | $54 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 133 | 105 | $182 |
In context: peer comparison
Among 4 peers in Redwood City Dermatology Physician, average services per provider: 206. This provider delivers 35× the peer median.Open Payments
Industry payments received
All-time total
$1,491
Transactions
57
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 15 | $288.70 | |
| Genzyme Corporation | 4 | $191.23 | |
| Sun Pharmaceutical Industries INC. | 5 | $138.03 | |
| Leo Pharma INC. | 5 | $121.62 | |
| Novartis Pharmaceuticals Corporation | 4 | $106.72 | |
| Pfizer INC. | 4 | $102.57 | |
| Ucb, INC. | 3 | $82.34 | |
| Arcutis Biotherapeutics, INC. | 4 | $76.27 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $70.76 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 2 | $60.20 | |
| Incyte Corporation | 2 | $56.30 | |
| Galderma Laboratories, L.P. | 2 | $55.30 | |
| Janssen Biotech, INC. | 2 | $43.23 | |
| Amgen INC. | 2 | $41.58 | |
| Lilly USA, LLC | 1 | $28.32 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
488
Patients
346
Total drug cost
$26,166
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ciclopirox (Ciclopirox Olamine) | Brand | 104 | 63 | $3,704 |
| Triamcinolone Acetonide | Generic | 95 | 73 | $1,642 |
| Mupirocin | Generic | 83 | 70 | $759 |
| Fluocinonide | Generic | 58 | 51 | $3,108 |
| Clobetasol Propionate | Generic | 33 | 20 | $2,382 |
| Fluorouracil | Generic | 30 | 25 | $3,024 |
| Tacrolimus | Generic | 26 | 22 | $7,282 |
| Imiquimod | Generic | 18 | 11 | $1,464 |
| Azelaic Acid | Generic | 15 | 0 | $1,414 |
| Desonide | Generic | 14 | 11 | $967 |
Frequently asked questions
What is Dr. John Yost's medical specialty?
Dr. John Yost practices Dermatology Physician in Redwood City, CA.
Where does Dr. John Yost practice?
Dr. John Yost practices at 450 Broadway St, Redwood City, CA 940633132. Office phone: 6507217190.
What is Dr. John Yost's NPI?
Dr. John Yost's National Provider Identifier (NPI) is 1336451137, issued by NPPES.
Does Dr. John Yost accept Medicare assignment?
Yes. Dr. John Yost accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. John Yost commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.